MRD 검사 시장 규모, 점유율 및 성장 분석 : 기술별, 방법별, 적응증별, 최종사용자별, 판매채널별, 지역별 - 업계 예측(2026-2033년)

Global Mrd Testing Market size was valued at USD 2.14 Billion in 2024 and is poised to grow from USD 2.41 Billion in 2025 to USD 6.3 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The global minimal residual disease (MRD) testing market is driven by the crucial need for highly sensitive detection of residual cancer cells, which surpasses traditional imaging methods. MRD testing plays a pivotal role in assessing prognosis, guiding treatment decisions, and monitoring therapeutic efficacy as it identifies relapse potential early, ultimately improving patient outcomes. Transitioning from conventional flow cytometry to advanced techniques like digital PCR and next-generation sequencing has significantly advanced sensitivity and precision. Enhanced assay interpretation fosters actionable clinical decisions, further stimulating market growth. The integration of AI significantly boosts sensitivity by refining signal extraction from circulating tumor DNA and enhancing variant calling. This technological evolution promotes broader clinical adoption and paves the way for comprehensive MRD applications, including solid tumors and longitudinal patient monitoring.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mrd Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mrd Testing Market Segments Analysis

Global mrd testing market is segmented by technology, method, indication, end-user, sales channel and region. Based on technology, the market is segmented into Next-Generation Sequencing, Flow Cytometry, Polymerase Chain Reaction and Others. Based on method, the market is segmented into Peripheral Blood Cell Testing, Methylation Sequencing Testing, High-Throughput Sequencing Testing and Others. Based on indication, the market is segmented into Hematological Malignancies, Solid Tumors and Others. Based on end-user, the market is segmented into Hospitals and Specialty Clinics, Diagnostic Laboratories, Research and Academic Institutes and Others. Based on sales channel, the market is segmented into Direct Sales, Medical Device Distributors, Online Healthcare Platforms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mrd Testing Market

The growth of the Global Minimal Residual Disease (MRD) Testing market is significantly propelled by advancements in high-sensitivity molecular detection technologies, which have improved the ability to identify residual cancer cells at much lower levels. This heightened sensitivity and specificity of assays enhances clinical confidence, enabling more accurate treatment decisions and effective monitoring of therapy and relapse. Consequently, this technological progress encourages a wider adoption of MRD testing services and platforms in various clinical environments. Additionally, it fosters collaboration between diagnostic developers and healthcare providers, while promoting investments for the implementation and validation of these critical tests.

Restraints in the Global Mrd Testing Market

The global Minimal Residual Disease (MRD) testing market faces significant constraints due to the high costs associated with advanced assays and the necessary instrumentation. These expenses can hinder the adoption of MRD testing among hospitals and laboratories, particularly those that prioritize competing budgetary demands and have limited resources. The financial burden influences critical decisions regarding test implementation, obtaining laboratory accreditation, and procuring specialized equipment, often preventing smaller clinical centers from providing MRD testing services. Additionally, cost-related issues can complicate discussions with payers, restricting access to testing for certain patient populations. As a result, these economic and operational challenges impede the overall growth and widespread acceptance of MRD testing in the market.

Market Trends of the Global Mrd Testing Market

The Global Minimal Residual Disease (MRD) Testing market is witnessing a prominent trend towards the integration of AI-driven diagnostics, as clinical laboratories and instrument manufacturers prioritize the incorporation of machine learning and predictive analytics into their workflows. This innovation aims to enhance signal detection and interpret complex molecular signatures, facilitating a more streamlined and consistent reporting process. The emphasis on reducing subjective interpretation fosters adaptive testing pathways to effectively respond to evolving biological patterns. Additionally, this trend promotes stronger collaboration between diagnostics developers and software vendors, leading to faster validation processes and greater alignment of laboratory workflows, ultimately translating algorithmic outputs into actionable information for improved treatment decisions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global MRD Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Next-Generation Sequencing
• Flow Cytometry
• Polymerase Chain Reaction
• Others

Global MRD Testing Market Size by Method & CAGR (2026-2033)

• Market Overview
• Peripheral Blood Cell Testing
• Methylation Sequencing Testing
• High-Throughput Sequencing Testing
• Others

Global MRD Testing Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Hematological Malignancies
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
• Solid Tumors
• Others

Global MRD Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Specialty Clinics
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

Global MRD Testing Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Medical Device Distributors
• Online Healthcare Platforms
• Others

Global MRD Testing Market Size & CAGR (2026-2033)

• North America (Technology, Method, Indication, End-User, Sales Channel)
  • US
  • Canada
• Europe (Technology, Method, Indication, End-User, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Method, Indication, End-User, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Method, Indication, End-User, Sales Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Method, Indication, End-User, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Adaptive Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArcherDX
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invivoscribe
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations